Status:

COMPLETED

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Lead Sponsor:

Hospital Clinic of Barcelona

Conditions:

HIV Infections

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The study compares the adherence of 240 HIV-negative subjects randomly assigned to 2 different antiretroviral therapies for 28 days after accidental exposure to HIV.

Eligibility Criteria

Inclusion

  • Age \> 18
  • HIV exposure requiring prophylaxis under current guidelines

Exclusion

  • Pregnancy
  • Suspected drug resistance in source case
  • Contraindications to the study drugs

Key Trial Info

Start Date :

May 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

255 Patients enrolled

Trial Details

Trial ID

NCT00385645

Start Date

May 1 2006

End Date

August 1 2009

Last Update

March 31 2010

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, Spain, 08916

2

Hospital del Mar

Barcelona, Barcelona, Spain, 08003

3

Hospital de Sant Pau

Barcelona, Barcelona, Spain, 08025

4

Hospital Vall d'Hebron

Barcelona, Barcelona, Spain, 08035

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis | DecenTrialz